<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> syndrome (APS) is a disorder caused by circulating antibodies reacting with biological membranes and characterized by <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It has been reported to occur either as a primary syndrome or secondary to systemic <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a case of primary APS in a young patient, in whom the clinical course was particularly severe and complicated by a <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was resistant to a number of treatments, and eventually responded to intravenous high dose <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
</text></document>